Evolent Health Closes Up 1.37% Despite Investigation into Technical Aspects
June 12, 2023
🌥️Trending News
Evolent Health ($NYSE:EVH) Inc., a health care technology and services company, recently closed up 1.37% at a closing price of $31.85. This prompted an investigation into the company’s technical aspects. Evolent Health Inc. provides population health management services to health systems, health plans, employers, and life sciences organizations. The company works to help its clients improve the quality of health care and control costs. The investigation into the company’s technical aspects is focused on how their stock is performing and if there are any underlying factors that could be causing the stock to increase in value. Analysts will be looking at the company’s financial reports to try and determine why the stock is performing so well.
Additionally, they will also be looking at the company’s operations, customer satisfaction, and other key metrics to determine if there are any hidden factors that could be contributing to the rise in stock price. Although Evolent Health Inc.’s stock rose 1.37%, it remains to be seen whether this will continue or if the investigation will uncover any underlying causes for the increase in value. Regardless, Evolent Health Inc. continues to provide healthcare technology and services to a wide array of clients in order to help them improve the quality of health care and reduce costs.
Analysis
At GoodWhale, we have conducted a thorough analysis on the fundamentals of EVOLENT HEALTH. Our Risk Rating indicates that it is a high risk investment, with potential risks stemming from both its financial and business aspects. During our analysis, we detected two risk warnings in its income sheet and balance sheet. To learn more about our findings and assessments, register on GoodWhale.com and check it out! More…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Evolent Health. More…
| Total Revenues | Net Income | Net Margin |
| 1.48k | -40.07 | -2.7% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Evolent Health. More…
| Operations | Investing | Financing |
| 37.91 | -670.87 | 562.65 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Evolent Health. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 2.59k | 1.47k | 7.63 |
Key Ratios Snapshot
Some of the financial key ratios for Evolent Health are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 18.3% | – | -8.1% |
| FCF Margin | ROE | ROA |
| 0.5% | -8.7% | -2.9% |
Peers
The company’s products and services enable healthcare providers to receive and process payments from patients and third-party payers. Evolent Health Inc’s competitors include PreAxia Health Care Payment Systems Inc, Livecare Inc, PT Bundamedik Tbk, and other healthcare payment processing companies.
– PreAxia Health Care Payment Systems Inc ($OTCPK:PAXH)
PreAxia Health Care Payment Systems Inc is a healthcare technology company that provides solutions to healthcare organizations and payers. Its products and services include claims processing, payment processing, and data management. The company was founded in 1997 and is headquartered in Boston, Massachusetts.
– Livecare Inc ($OTCPK:LVCE)
The companyPT Bundamedik Tbk is a leading healthcare provider in Indonesia. The company has a market cap of 4.73T as of 2022 and a ROE of 10.69%. The company is focused on providing quality healthcare services to the Indonesian people. The company has a strong presence in the Indonesian healthcare market and is committed to providing the best possible care to its patients.
Summary
Evolent Health Inc. has seen a rise of 1.37% in its closing price, reaching $31.85. An analysis of the company’s technical aspects is important for prospective investors. Evolent Health Inc. offers technology and services that enable health care providers to better manage population health and transition into value-based payment models. Its platform helps providers to improve patient outcomes, reduce costs, and keep pace with emerging regulatory requirements.
Through its advanced data analytics and machine learning capabilities, EVOLENT can help providers understand patient risk, identify gaps in care and execute on a care plan that is tailored to the individual’s needs. Investors should take into consideration the competitive landscape as well as the company’s financial performance before making an investment decision.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
